Skip to Content

Did you read the recent headlines about the newly released study concluding that even after women (in the study) completed five years of hormone therapy, their recurrence risk continued for twenty years and likely beyond? The implication is that women diagnosed with early stage, hormone-positive breast cancer and who are taking hormone-blocking drugs, should strongly …

Read More about Should Certain Breast Cancer Patients Extend Endocrine Therapy Beyond Five Years?

Breast cancer treatment’s collateral damage — let’s talk about it. Yes, let’s. This post has been sitting in my draft folder for a while. Sometimes, I hesitate to write about breast cancer treatment’s collateral damage (aka cancer crap fallout) that goes on and on and on following a cancer diagnosis. Notice I say, following a …

Read More about Breast Cancer Treatment’s Collateral Damage – Let’s Talk About It